AMN Healthcare Services, Inc.

NYSE•AMN

CEO: Ms. Caroline Sullivan Grace

Sector: Healthcare

Industry: Medical - Care Facilities

Listing Date: 2001-11-13

AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The Nurse and Allied Solutions segment offers travel nurse staffing, labor disruption staffing, local staffing, international nurse and allied permanent placement, and allied staffing solutions. The Physician and Leadership Solutions segment provides locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. The Technology and Workforce Solutions segment offers language services, vendor management systems, workforce optimization, and outsourced solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists. It offers its services under the brands, including AMN Healthcare, Nursefinders, HealthSource Global Staffing, O'Grady Peyton International, Connetics, Medical Search International, DRW Healthcare Staffing, and B.E. Smith. AMN Healthcare Services, Inc. was founded in 1985 and is headquartered in Dallas, Texas.

Contact Information

8840 Cypress Waters Boulevard, Suite 300, Dallas, TX, 75019, United States

866-871-8519

www.amnhealthcare.com

Market Cap

$703.27M

P/E (TTM)

-7.4

14.5

Dividend Yield

52W High

$23.74

52W Low

$14.87

52W Range

38%

Rank24Top 10.8%

5.7

F-Score

Modified Piotroski Analysis

Based on 10-year fundamentals

Average • 5.7 / 9 points

Scoring Range (0-9)

8-9: Excellent Value

6-7: Strong Fundamentals

4-5: Average Quality

0-3: Weak Performance

Data Period: 2016-2025

Financial Dashboard

Q4 2025 Data

Revenue

$748.23M+0.00%

4-Quarter Trend

EPS

-$0.20+0.00%

4-Quarter Trend

FCF

$67.63M+0.00%

4-Quarter Trend

2025 Annual Earnings Highlights

Key Highlights

Net Loss Significantly Narrows Net loss reduced to $(95.7)M in 2025 from $(147.0)M loss in 2024, showing margin recovery efforts.

Labor Disruption Revenue Boost Nurse and allied segment revenue gained $127.9M from labor disruption support during Q4 2025 events.

Major Debt Redemption Completed Successfully redeemed $500.0M aggregate principal amount of 2027 Senior Notes during the fourth quarter of 2025.

Operating Cash Flow Remains Strong Cash provided by operating activities totaled $269.5M for 2025, supporting liquidity needs and capital structure.

Risk Factors

Overall Revenue Declined Consolidated revenue fell 8% to $2.73B in 2025, driven by declines across all reportable segments.

Significant Impairment Charges Recognized $109.5M goodwill impairment and $18.3M long-lived asset impairment during the fiscal year 2025.

Gross Margin Compression Gross margin decreased to 28.3% in 2025 from 30.8% in 2024 due to pay package costs and sales mix.

High Client Concentration Risk Kaiser Foundation Hospitals represented 22% of 2025 consolidated revenue, posing material adverse effect risk if lost.

Outlook

Investing in Technology & AI Increasing investments in automation and AI-enabled technology to realize greater scale, agility, speed, and cost efficiencies.

Expanding Talent Solutions Strategy focuses on market penetration, expanding talent solutions, and increasing qualified healthcare professional supply through 2026.

Human Capital Management Focus Strategy prioritizes talent acquisition, engagement, retention, and well-being for corporate team members and professionals.

Peer Comparison

Revenue (TTM)

AMN

$2.73B

-8.5%

EVH

$1.88B

-26.6%

PNTG

$947.71M

+36.3%

Gross Margin (Latest Quarter)

VIR

672.1%

-54902.1pp

IOVA

215.9%

+65.9pp

AIRS

200.8%

+3.0pp

Key Metrics

Symbol	Market Cap	P/E (TTM)	ROE (TTM)	Debt to Assets
VIR	$1.45B	-2.9	-49.3%	18.6%
IOVA	$1.14B	-3.6	-54.5%	5.3%
BFLY	$1.05B	-13.5	-35.3%	6.9%

Long-Term Trends

Last 4 Quarters

Revenue

Net Income

Operating Cash Flow

4Q Revenue CAGR

2.8%

Moderate Growth

4Q Net Income CAGR

N/M

Profitability Shift

Cash Flow Stability

100%

Strong Cash Flow

Deep Research

Next earnings:Apr 30, 2026

EPS:$1.62

Revenue:$1.23B

Financials

Earnings Calls

Reports

News

Income Statement

Balance Sheet

Cash Flow Statement

Ratios

% Chg.

Income Statement	LTM

No Data